The clinical suspicion of local recurrence of prostate cancer (PCa) after radical
prostatectomy (RP) and after radiation therapy (RT) is based on the onset of biochemical …

BACKGROUND: Recent reports using extreme hypofractionated regimens in the treatment
of low‐risk prostate adenocarcinoma have been encouraging. Here, the authors report on …

CONTEXT: Prostate cancer (PCa) is the most common cancer in men. Permanent interstitial
low-dose-rate brachytherapy (LDR-BT) is a short-distance radiation therapy in which low …

Purpose To compare diagnostic accuracy of T2-weighted magnetic resonance (MR) imaging
with that of multiparametric (MP) MR imaging combining T2-weighted imaging with diffusion …

Objective To evaluate the clinical and biochemical effects of long‐acting testosterone
undecanoate injections in men with prostate cancer treated with brachytherapy, as the use …

Background Carbon-ion radiotherapy (CIRT) for prostate cancer was initiated at Kanagawa
Cancer Center in 2015. The present study analyzed the preliminary clinical outcomes of …

Background: Interstitial brachytherapy for localised prostate cancer may be followed by
transient increases in prostate-specific antigen (PSA) that resolve without therapy. Such PSA …

Abstract Introduction The sub Comittee prostate of the CCAFU established guidelines for
diagnostic, treatment, evaluation and standart of care of prostate cancer. Methods …

PURPOSE: To evaluate the prostate-specific antigen (PSA) kinetics of PSA failure (PSAf)
and PSA bounce (PSAb) after permanent 125I prostate brachytherapy (PB). METHODS AND …

TMPRSS2–ERG rearrangements occur in approximately 50% of prostate cancers and
therefore represent one of the most frequently observed structural rearrangements in all …